Patent Number: 8,791,094

Title: Treatment of prostate cancer

Abstract: Described herein are compounds, methods of making such compounds, pharmaceutical compositions, and medicaments comprising such compounds, and methods of using such compounds to treat androgen receptor mediated diseases or conditions. Such compounds include inhibitors of cytochrome C17.sub..alpha.-hydroxylase/C.sub.17,20-lyase such as 3-.beta.-Hydroxy-17-(1H-benzimidazol-1-yl)androsta-5,16-diene.

Inventors: Morrison; Jodie Pope (Wakefield, MA), Stein; Cy Aaron (New City, NY), Casebier; David Scott (Carlisle, MA)

Assignee: Tokai Pharmaceuticals, Inc.

International Classification: A61K 31/58 (20060101); C07J 43/00 (20060101)

Expiration Date: 7/29/12018